Speakers at ICG-13

Speakers at ICG-13

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Biography

Mylynda B. Massart, M.D., Ph.D., is a Family Medicine physician at UPMC, and assistant professor at the University of Pittsburgh. She completed her doctoral degree at the University of Utah in Molecular Biology/Biochemistry and her medical degree from Oregon Health Sciences University. She currently serves as the medical director at UPMC Matilda Theiss Health Center, and as co-director for the HUB Core: Integrating Special Populations at the Clinical and Translational Science Institute (CSTI). Dr. Massart has experience working with diverse populations across the lifespan including obstetrics, pediatrics, adults, and older adults. She has served in the National Health Service Core in Idaho working with a rural population and currently works in an underserved community in Pittsburgh. Her research interests are in developing education in genetics and precision medicine for primary care providers and trainees and to be a research catalyst facilitating the inclusion of underrepresented populations in biomedical research. Dr. Massart currently serves as a co-investigator on the All of Us PA project as well as the Pitt+Me Discovery Biobank. She teaches residents and medical students in her clinic and at the hospital and serves as medical director for Bethany Hospice. 


Abstract

The era of precision medicine is here, and the University of Pittsburgh and the University of Pittsburgh Medical Center are dedicated to precision medicine research and its direct translation to the bedside.  Dr. Mylynda Massart will introduce the All of Us National Precision Medicine research program that launched first at the University of Pittsburgh in 2017 and recently launched across the nation.  This transformative national longitudinal endeavor will assemble a 1 million person research cohort to advance precision medicine research.  In addition, she will highlight the local Pitt+Me Discovery Biobank that has now launched and detail the plans for pharmacogenomic testing of these samples with subsequent return of results to participants and their providers through the UPMC health system.  Finally, Dr. Massart will present an overview of some of the major remaining challenges and proposed solutions for the integration of “omics” and precision medicine into clinical practice.

PREV
NEXT
Join Mailing List